Transforming lives with stem cell medicine

Bringing together research excellence to harness the therapeutic potential in stem cell medicine


Melissa Little
Professor and CEO

reNEW – a unique global research center in stem cell medicine

reNEW is an international consortium of three leading research institutions in Denmark, Australia and the Netherlands, led by renowned Professor and CEO Melissa Little. We strive to advance a new generation of effective and safe stem cell-based therapies, built on a global collaborative network of excellence in targeted biomedical research.

Our mission is to develop an international targeted research center to deliver innovative stem cell driven therapies to transform the lives of people with incurable disease

Translating research into new stem cell medicine

The aim of the center is to strengthen the pathway from stem cell discovery research to clinical outcomes. We will apply our understanding of stem cells to improve drug development and deliver novel cell and tissue therapies.

Scientist looking through high end microscope

Meet our leading scientists

Leading scientists from around the globe collaborate to transform the world of stem cell medicine

Understanding stem cells and how they can be used

A stem cell can renew itself and generate other cell types. We all rely on stem cells to exist and to survive. Understanding stem cells and their potential has long been of interest to researchers across the globe. Stem cell medicine refers to the application of that understanding to accelerate the development of new therapies for people living with incurable diseases.

Mother and Son touching foreheads

Be part of transformative science

Join us in delivering the next generation of effective and safe stem cell-based therapies. reNEW is situated in three places – Copenhagen, Leiden and Melbourne. But no matter where in the world you are, you can help us transform the future of stem cell medicine.

Impacting the world with our science

Find out the latest in the world of stem cell medicine.

Esteemed colleagues from reNEW elected members of EMBO

The Novo Nordisk Foundation Center for Stem Cell Medicine is proud to announce that CEO and Executive Director of reNEW, Professor Mellissa H. Little and Principal Investigator at reNEW’s Copenhagen node, Professor Joshua Brickman, have this year been elected members of the prestigious European Molecular Biology Organization – EMBO.

4M euros for research into nuclear metabolism

Associate Professor Jan Żylicz from reNEW Copenhagen node, as part of an international consortium, has been awarded an MSCA Doctoral Networks Grant for project; NUCLEAR – metabolic regulation of genome function and cell identity.

The Serup Group in Copenhagen break new ground on the development of a stem cell therapy to treat diabetes

Assistant Professor Philip Seymour, former Assistant Professor Nina Funa and PhD student Heidi Mjøseng, with colleagues from the Serup Group at the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, University of Copenhagen, have had a paper published in Stem Cell Reports investigating further development of a cellular therapy to replace the lost insulin-producing beta cells in type one diabetics.